MILFORD, Mass.--(BUSINESS WIRE)--SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced three presentations at the Clinical Virology Symposium held April 19-22, 2009 in Daytona Beach, FL based on scientific data generated in the Company’s research programs. These data support SeraCare’s plans to expand their diagnostic controls product portfolio later this year with a new genotype panel for human papillomavirus, the virus that can lead to cervical cancer, and a suite of quality controls to support testing for the sexually transmitted diseases (STDs) chlamydia and gonorrhea.
